Potentially, we are talking about a revolution in medicine
The key feature of the method is the use of a specially bred virus. Scientists infect cancer cells with it and make them more susceptible to the work of the immune system.
The first phase of the trial involves 100 patients. All of them have metastatic tumors. First, they will be injected with the virus, after which they will begin a course of immunotherapy.
It is reported that in preclinical trials, this method has shown excellent results. Including in the fight against colon, lung, breast and ovarian cancer in animals.
The estimated time frame for the mass introduction of the new methodology remains unknown.